Zhou Qin, Lan Yang, Wang Yuancheng, Zhao Yun, Wu Zhaolong
Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zhonghua Yi Xue Za Zhi. 2002 Oct 10;82(19):1346-50.
To clarify whether the activating protein-1 (AP-1) is involved in the transcriptional regulation of expression of oxidized low density lipoprotein (Ox-LDL) induced transforming growth factor (TGF)-beta(1) gene and further to investigate the possible signal transduction pathway in the cultured mesangial cells (MsCs).
Firstly, a deletion analysis of SD rat renal mesangial TGF-beta(1) promoter (pRT)--luciferase reporter genes was adopted to identify the possible regulatory regions responding to Ox-LDL. With mutation of AP-1 binding site and addition of the c-Jun/AP-1 inhibitor curcumin, the changes of relative luciferase of pRT stimulated by Ox-LDL were assayed, respectively. Furthermore, the phosphorylation of p38MAPK was detected by Western blotting. Pre-treatment with the different specific kinase inhibitors, the activities of AP-1 induced by Ox-LDL were determined by electrophoretic mobility shift assay (EMSA).
Relative luciferase activity showed two regions responding to stimulation by Ox-LDL in rat TGF-beta(1) promoter: one positive regulatory region (-1 550 to -845) containing an accurate AP-1 binding site, and one negative (-629 to -422) regulatory region. Both mutation of AP-1 binding site and addition of curcumin markedly decrease of activity of TGF-beta(1) promoter. The phosphorylation, but not total protein, of p38MAPK was significantly enhanced by Ox-LDL stimulation. The inhibitor of PKC remarkably reduced the activity of AP-1 induced by Ox-LDL. Reversely, the activity of AP-1 didn't significantly change with the inhibitor of p38MAPK.
In the cultured rat mesangial cells, the AP-1 complex regulates Ox-LDL induced-overproduction of TGF-beta(1) at the transcriptional level. Furthermore, the functional and structural results showed that Ox-LDL regulates rat TGF-beta(1) gene expression through AP-1 binding site and c-Jun/AP-1 complex, it gives rise to the involvement of protein kinase C, but not p38MAPK, in Ox-LDL-induced TGF-beta(1) gene expression.
阐明活化蛋白-1(AP-1)是否参与氧化型低密度脂蛋白(Ox-LDL)诱导的转化生长因子(TGF)-β1基因表达的转录调控,并进一步研究其在培养的系膜细胞(MsCs)中的可能信号转导途径。
首先,采用对SD大鼠肾系膜TGF-β1启动子(pRT)-荧光素酶报告基因进行缺失分析,以确定对Ox-LDL作出反应的可能调控区域。通过AP-1结合位点的突变以及添加c-Jun/AP-1抑制剂姜黄素,分别检测Ox-LDL刺激下pRT相对荧光素酶的变化。此外,通过蛋白质印迹法检测p38MAPK的磷酸化。用不同的特异性激酶抑制剂进行预处理,通过电泳迁移率变动分析(EMSA)测定Ox-LDL诱导的AP-1活性。
相对荧光素酶活性显示大鼠TGF-β1启动子中有两个区域对Ox-LDL刺激作出反应:一个阳性调控区域(-1 550至-845)包含一个精确的AP-1结合位点,以及一个阴性(-629至-422)调控区域。AP-1结合位点的突变和姜黄素的添加均显著降低TGF-β1启动子的活性。Ox-LDL刺激显著增强了p38MAPK的磷酸化水平,而非总蛋白水平。蛋白激酶C(PKC)抑制剂显著降低了Ox-LDL诱导的AP-1活性。相反,p38MAPK抑制剂处理后AP-1活性没有显著变化。
在培养的大鼠系膜细胞中,AP-1复合物在转录水平上调节Ox-LDL诱导的TGF-β1过度产生。此外,功能和结构研究结果表明,Ox-LDL通过AP-1结合位点和c-Jun/AP-1复合物调节大鼠TGF-β1基因表达,提示蛋白激酶C参与了Ox-LDL诱导的TGF-β1基因表达,而p38MAPK未参与。